102 related articles for article (PubMed ID: 19212891)
21. Novel self-assembled core-shell nanoparticles based on crystalline amorphous moieties of aliphatic copolyesters for efficient controlled drug release.
Papadimitriou S; Bikiaris D
J Control Release; 2009 Sep; 138(2):177-84. PubMed ID: 19446585
[TBL] [Abstract][Full Text] [Related]
22. Polyethylene glycol-coated liposomes for oral delivery of recombinant human epidermal growth factor.
Li H; Song JH; Park JS; Han K
Int J Pharm; 2003 Jun; 258(1-2):11-9. PubMed ID: 12753749
[TBL] [Abstract][Full Text] [Related]
23. Biodegradable microparticles and fiber fabrics for sustained delivery of cisplatin to treat C6 glioma in vitro.
Xie J; Tan RS; Wang CH
J Biomed Mater Res A; 2008 Jun; 85(4):897-908. PubMed ID: 17896769
[TBL] [Abstract][Full Text] [Related]
24. A novel strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice.
Gainza G; Pastor M; Aguirre JJ; Villullas S; Pedraz JL; Hernandez RM; Igartua M
J Control Release; 2014 Jul; 185():51-61. PubMed ID: 24794895
[TBL] [Abstract][Full Text] [Related]
25. The topical administration of rhEGF-loaded nanostructured lipid carriers (rhEGF-NLC) improves healing in a porcine full-thickness excisional wound model.
Gainza G; Bonafonte DC; Moreno B; Aguirre JJ; Gutierrez FB; Villullas S; Pedraz JL; Igartua M; Hernandez RM
J Control Release; 2015 Jan; 197():41-7. PubMed ID: 25449803
[TBL] [Abstract][Full Text] [Related]
26. Preparation, characterization, and in vivo evaluation of insulin-loaded PLA-PEG microspheres for controlled parenteral drug delivery.
Sheshala R; Peh KK; Darwis Y
Drug Dev Ind Pharm; 2009 Nov; 35(11):1364-74. PubMed ID: 19832637
[TBL] [Abstract][Full Text] [Related]
27. Preparation and characterization of PLGA microspheres containing a staphylokinase variant (K35R).
He JT; Tao XM; Mo W; Song HY
Yao Xue Xue Bao; 2006 Jan; 41(1):12-8. PubMed ID: 16683521
[TBL] [Abstract][Full Text] [Related]
28. Formulation and in vitro characterization of spray-dried antisense oligonucleotide to NF-kappaB encapsulated albumin microspheres.
Gayakwad SG; Bejugam NK; Akhavein N; Uddin NA; Oettinger CE; D'Souza MJ
J Microencapsul; 2009 Dec; 26(8):692-700. PubMed ID: 19888878
[TBL] [Abstract][Full Text] [Related]
29. Enhanced percutaneous delivery of recombinant human epidermal growth factor employing nano-liposome system.
Jeon SO; Hwang HJ; Oh DH; Seo JE; Chun KH; Hong SM; Kim MJ; Kim WC; Park MS; Yoon CH; Min KH; Suh CW; Lee S
J Microencapsul; 2012; 29(3):234-41. PubMed ID: 22214321
[TBL] [Abstract][Full Text] [Related]
30. Optimizing formulation factors in preparing chitosan microparticles by spray-drying method.
Huang YC; Chiang CH; Yeh MK
J Microencapsul; 2003; 20(2):247-60. PubMed ID: 12554378
[TBL] [Abstract][Full Text] [Related]
31. Novel drug-loaded gelatin films and their sustained-release performance.
Lin M; Meng S; Zhong W; Cai R; Du Q; Tomasik P
J Biomed Mater Res B Appl Biomater; 2009 Aug; 90(2):939-44. PubMed ID: 19365822
[TBL] [Abstract][Full Text] [Related]
32. Controlled release of rhEGF and rhbFGF from electrospun scaffolds for skin regeneration.
Mirdailami O; Soleimani M; Dinarvand R; Khoshayand MR; Norouzi M; Hajarizadeh A; Dodel M; Atyabi F
J Biomed Mater Res A; 2015 Oct; 103(10):3374-85. PubMed ID: 25856734
[TBL] [Abstract][Full Text] [Related]
33. Preparation of redispersible liposomal dry powder using an ultrasonic spray freeze-drying technique for transdermal delivery of human epithelial growth factor.
Yin F; Guo S; Gan Y; Zhang X
Int J Nanomedicine; 2014; 9():1665-76. PubMed ID: 24729702
[TBL] [Abstract][Full Text] [Related]
34. Influence of excipients on characteristics and release profiles of poly(ε-caprolactone) microspheres containing immunoglobulin G.
Erdemli Ö; Keskin D; Tezcaner A
Mater Sci Eng C Mater Biol Appl; 2015 Mar; 48():391-9. PubMed ID: 25579939
[TBL] [Abstract][Full Text] [Related]
35. In situ forming biodegradable poly(ε-caprolactone) microsphere systems: a challenge for transarterial embolization therapy. In vitro and preliminary ex vivo studies.
Salis A; Porcu EP; Gavini E; Fois GR; Icaro Cornaglia A; Rassu G; Diana M; Maestri M; Giunchedi P; Nikolakakis I
Expert Opin Drug Deliv; 2017 Apr; 14(4):453-465. PubMed ID: 28276966
[TBL] [Abstract][Full Text] [Related]
36. Effect of protease inhibitors on degradation of recombinant human epidermal growth factor in skin tissue.
Ryou HW; Lee JW; Yoon KA; Park ES; Chi SC
Arch Pharm Res; 1997 Feb; 20(1):34-8. PubMed ID: 18975209
[TBL] [Abstract][Full Text] [Related]
37. Transport of epidermal growth factor in the stroke-injured brain.
Wang Y; Cooke MJ; Lapitsky Y; Wylie RG; Sachewsky N; Corbett D; Morshead CM; Shoichet MS
J Control Release; 2011 Feb; 149(3):225-35. PubMed ID: 21035512
[TBL] [Abstract][Full Text] [Related]
38. Recombinant human epidermal growth factor accelerates the proliferation of irradiated human fibroblasts and keratinocytes in vitro and in vivo.
Ryu SH; Moon SY; Yang YJ; Moon SR; Hong JP; Choi J; Lee SW
J Radiat Res; 2009 Nov; 50(6):545-52. PubMed ID: 19959882
[TBL] [Abstract][Full Text] [Related]
39. Microencapsulation of superoxide dismutase into poly(epsilon-caprolactone) microparticles by reverse micelle solvent evaporation.
Youan BB
Drug Deliv; 2003; 10(4):283-8. PubMed ID: 14612345
[TBL] [Abstract][Full Text] [Related]
40. Nanoencapsulation in lipid-core nanocapsules controls mometasone furoate skin permeability rate and its penetration to the deeper skin layers.
Melero A; Ferreira Ourique A; Stanisçuaski Guterres S; Raffin Pohlmann A; Lehr CM; Ruver Beck RC; Schaefer U
Skin Pharmacol Physiol; 2014; 27(4):217. PubMed ID: 24751514
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
